Workflow
团体生物反馈仪
icon
Search documents
伟思医疗(688580.SH)业绩快报:2025年归母净利润1.37亿元,同比增加33.99%
Ge Long Hui A P P· 2026-02-26 07:57
报告期内,公司依托产品竞争力提升与营销体系优化升级的共同驱动,经营规模稳步扩大,业务结构持 续改善,整体发展态势稳健向好。研发创新层面,公司坚持以研发创新驱动业务增长,报告期内持续巩 固在磁刺激、电生理、电刺激等领域的技术领先优势,并加速激光、射频等能量源技术的产业化落地, 全线产品市场竞争力显著增强。其中,核心产品矩阵表现亮眼,经颅磁刺激仪、团体生物反馈仪、盆底 射频机器人及配套耗材等主力品种销量实现较快增长,市场渗透率稳步提升,终端反馈积极向好。市场 营销层面,公司深化营销体系改革,渠道网络建设全面提速,新客户拓展效率与终端覆盖度同步提升; 受益于康复医疗市场需求持续释放,精神康复、盆底康复、神经康复三大业务板块协同发力,共同驱动 销售业绩稳健提升。展望后续,公司将继续强化核心产品竞争力,完善国内外渠道建设,加快海外注册 准入,并推行精益生产管理,依托康复业务与新兴板块的协同发展,推动经营业绩保持稳健、可持续的 增长态势。 格隆汇2月26日丨伟思医疗(688580.SH)公布2025年度业绩快报,本报告期,公司实现营业总收入4.63亿 元,同比增加15.66%;营业利润1.51亿元,同比增加 35.03% ...
伟思医疗:公司产品已全面覆盖国内各类医疗机构
Zheng Quan Ri Bao Wang· 2025-11-20 12:47
Core Viewpoint - Weisi Medical emphasizes its commitment to research and innovation as the driving force behind its competitive advantage in the rehabilitation medical device sector [1] Group 1: Company Overview - Weisi Medical is a technology-driven enterprise in the domestic rehabilitation medical device field, focusing on continuous R&D investment and precise market positioning [1] - The company has established significant competitive advantages in various niche markets, maintaining excellent profitability and market share [1] Group 2: Product Coverage and Market Position - The company's products cover a wide range of domestic medical institutions, including general hospitals, obstetrics, psychiatry, pediatrics, and rehabilitation specialty hospitals [1] - In key niche markets such as pelvic and postpartum rehabilitation, mental health, and pediatric rehabilitation, Weisi Medical ranks among the top domestic manufacturers [1] - Core products like transcranial magnetic stimulators, pelvic magnetic stimulators, and group biofeedback devices are leading in market sales compared to similar products [1] Group 3: Future Strategy - Looking ahead, the company plans to strengthen its R&D engine, accelerate the localization of high-end equipment, and deepen the layout of rehabilitation clinical solutions [1] - The goal is to consolidate its position as a technology leader in the industry and to drive the overall upgrade of China's rehabilitation medical industry [1]